Huawei Smart Watch Ecg

The Huawei ECG smartwatch market in 2026 is defined by a shift toward medical-grade certification and "premiumization," with Huawei securing a strong global position through its TruSense sensor ecosystem. Current product trends highlight the integration of ECG with advanced health metrics like Ambulatory Blood Pressure Monitoring (ABPM) and arterial stiffness detection.

Product Insights (2026 Lineup)

Huawei's ECG offerings are concentrated in three key series, each targeting distinct user needs:

• HUAWEI Watch GT 5 Pro: Focuses on professional sports and lifestyle aesthetics (Titanium/Ceramic). It features real-time 30-second ECG analysis and Pulse Wave Arrhythmia Analysis for A-fib screening. HuaweiWareable
• HUAWEI Watch D2: A dedicated medical health watch. It is the first to offer integrated ABPM via an inflatable strap, providing hospital-grade blood pressure accuracy (±3 mmHg) alongside full ECG support. Medicalexpo
• HUAWEI Watch 5 Series: Features a new "X-Tap" sensor designed for enhanced ECG signal collection and responsiveness. Youtube

Market Trends & Certification

The demand for ECG wearables peaked in early 2026, driven by an aging population and rising interest in preventative heart health.

• Regulatory Landscape: ECG features require medical device certification (e.g., CE MDR in the EU) before being activated. Huawei has successfully certified the Watch GT 5 Pro and Watch D2 in major markets including Europe, Japan, Brazil, and parts of the Middle East. HuaweiMedicalexpo
• Consumer Sentiment: Accuracy is a primary driver; the GT 5 Pro is highly rated for matching gold-standard Garmin and Oura devices in health tracking. However, users frequently cite the lack of a third-party app ecosystem as a key drawback compared to Wear OS competitors. Wareable

The following product files provide current B2B listings for wholesale sourcing and technical comparisons.